West Pharmaceutical Services PE Ratio 2010-2025 | WST

Current and historical p/e ratio for West Pharmaceutical Services (WST) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. West Pharmaceutical Services PE ratio as of June 05, 2025 is 31.84.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

West Pharmaceutical Services PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-06-05 218.58 34.31
2025-03-31 223.66 $6.37 35.11
2024-12-31 327.03 $6.69 48.88
2024-09-30 299.48 $6.74 44.43
2024-06-30 328.43 $7.03 46.72
2024-03-31 394.34 $7.58 52.02
2023-12-31 350.71 $7.88 44.51
2023-09-30 373.49 $7.41 50.40
2023-06-30 380.52 $6.86 55.47
2023-03-31 344.53 $7.28 47.33
2022-12-31 233.86 $7.72 30.29
2022-09-30 244.32 $8.29 29.47
2022-06-30 300.02 $9.01 33.30
2022-03-31 407.32 $9.00 45.26
2021-12-31 464.92 $8.70 53.44
2021-09-30 420.66 $8.06 52.19
2021-06-30 355.65 $6.84 52.00
2021-03-31 278.93 $5.58 49.99
2020-12-31 280.28 $4.58 61.20
2020-09-30 271.80 $4.13 65.81
2020-06-30 224.48 $3.79 59.23
2020-03-31 150.30 $3.46 43.44
2019-12-31 148.26 $3.20 46.33
2019-09-30 139.71 $3.05 45.80
2019-06-30 123.13 $3.03 40.64
2019-03-31 108.29 $2.90 37.34
2018-12-31 96.19 $2.75 34.98
2018-09-30 120.99 $2.06 58.73
2018-06-30 97.16 $2.00 48.58
2018-03-31 86.26 $1.76 49.01
2017-12-31 96.26 $1.99 48.37
2017-09-30 93.77 $2.51 37.36
2017-06-30 91.95 $2.34 39.30
2017-03-31 79.26 $2.43 32.62
2016-12-31 82.27 $1.92 42.85
2016-09-30 72.12 $1.85 38.98
2016-06-30 73.34 $1.37 53.53
2016-03-31 66.89 $1.15 58.16
2015-12-31 57.98 $1.30 44.60
2015-09-30 52.00 $1.28 40.62
2015-06-30 55.70 $1.69 32.96
2015-03-31 57.63 $1.83 31.49
2014-12-31 50.85 $1.76 28.89
2014-09-30 42.65 $1.66 25.69
2014-06-30 40.09 $1.60 25.05
2014-03-31 41.77 $1.51 27.66
2013-12-31 46.43 $1.58 29.38
2013-09-30 38.86 $1.55 25.07
2013-06-30 33.09 $1.40 23.72
2013-03-31 30.49 $1.19 25.62
2012-12-31 25.62 $1.15 22.37
2012-09-30 24.74 $1.12 22.19
2012-06-30 23.46 $1.15 20.49
2012-03-31 19.67 $1.21 16.32
2011-12-31 17.47 $1.08 16.18
2011-09-30 17.00 $0.90 18.89
2011-06-30 19.98 $0.91 21.95
2011-03-31 20.36 $0.94 21.78
2010-12-31 18.66 $0.94 19.85
2010-09-30 15.47 $1.15 13.51
2010-06-30 16.37 $1.14 14.36
2010-03-31 18.75 $1.12 16.82
2009-12-31 17.45 $1.06 16.46
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $15.190B $2.893B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.762B 21.43
Becton Dickinson (BDX) United States $48.993B 12.13
Cardinal Health (CAH) United States $36.773B 19.26
Labcorp (LH) United States $21.291B 17.27
Straumann Holding AG (SAUHY) Switzerland $20.490B 0.00
Cooper (COO) United States $13.483B 17.38
Align Technology (ALGN) United States $13.047B 25.90
Henry Schein (HSIC) United States $8.568B 14.69
Merit Medical Systems (MMSI) United States $5.571B 26.93
DENTSPLY SIRONA (XRAY) United States $3.209B 9.58
CONMED (CNMD) United States $1.750B 13.10
STAAR Surgical (STAA) United States $0.826B 0.00
Lifevantage (LFVN) United States $0.160B 16.49
Pro-Dex (PDEX) United States $0.135B 14.73